BioPen developed, uses 3D printing methods to 'draw' live cells onto patients

Advertisement
By Press Trust of India | Updated: 26 December 2013 19:06 IST
Doctors may soon be able to 'draw' new bone, skin and muscle on to patients, after scientists created a pen-like device that can apply human cells directly on to seriously injured people.
 
The device contains stem cells and growth factors and will give surgeons greater control over where the materials are deposited.
 
It will also reduce the time the patient is in surgery by delivering live cells and growth factors directly to the site of injury, accelerating the regeneration of functional bone and cartilage, scientists said.
 
The device developed at the University of Wollongong (UOW) will eliminate the need to harvest cartilage and grow it for weeks in a lab.
 
The BioPen works similar to 3D printing methods by delivering cell material inside a bio-polymer such as alginate, a seaweed extract, protected by a second, outer layer of gel material.
 
The two layers of gel are combined in the pen head as it is extruded onto the bone surface and the surgeon 'draws' with the ink to fill in the damaged bone section.
 
A low powered ultra-violet light source is fixed to the device that solidifies the inks during dispensing, providing protection for the embedded cells while they are built up layer-by-layer to construct a 3D scaffold in the wound site.
 
Once the cells are 'drawn' onto the surgery site they will multiply, become differentiated into nerve cells, muscle cells or bone cells and will eventually turn from individual cells into a thriving community of cells in the form of a functioning a tissue, such as nerves, or a muscle.
 
The device can also be seeded with growth factors or other drugs to assist regrowth and recovery, while the hand-held design allows for precision in theatre and ease of transportation.
 
The BioPen prototype was designed and built using the 3D printing equipment in the labs at Wollongong and was handed over to clinical partners at St Vincent's Hospital Melbourne, led by Professor Peter Choong, who will work on optimising the cell material for use in clinical trials.
 
"This type of treatment may be suitable for repairing acutely damaged bone and cartilage, for example from sporting or motor vehicle injuries," Choong, Director of Orthopaedics at St Vincent's Hospital Melbourne said.

Get your daily dose of tech news, reviews, and insights, in under 80 characters on Gadgets 360 Turbo. Connect with fellow tech lovers on our Forum. Follow us on X, Facebook, WhatsApp, Threads and Google News for instant updates. Catch all the action on our YouTube channel.

Advertisement

Related Stories

Popular Mobile Brands
  1. iPhone Duo Screen Repair Costs Almost as Much as an iPhone 18 Pro
  2. Redmi K100 Could Launch Soon at This Price: See Expected Specifications
  3. BGMI Air Gets New Name as Krafton Prepares Lighter Battle Royale Experience
  4. Amazon Great Indian Festival 2026: Best Deals on LG Products
  5. These Old Galaxy Flagships Are Getting the Stable One UI 9 Update
  6. iQOO Pad Pro 8.8 Launch Confirmed; Specifications Teased
  1. PS Plus Game Catalogue Will Add Mafia: The Old Country, Mycopunk, The Midnight Walk and More in October
  2. Oppo Wide-Folding Phone Key Display Features Tipped Ahead of Launch: Expected Specifications
  3. Google Play Store ‘Shop Devices’ Feature Goes Live in India With Pixel Phones and Accessories
  4. US Crypto Scam Crackdown Brings 241 Website Shutdowns by FBI, Brooklyn DA
  5. Logitech Starts Local Manufacturing in India, Products to Roll Out From Manesar Plant
  6. OnePlus Ace 7, Ace 7 Pro Listed on Google Supported Devices List Ahead of Launch
  7. iPhone Duo Screen Repair in India Costs Almost as Much as an iPhone 18 Pro
  8. DoT Mandates Caller Name Presentation for 5G and 4G Networks From Next Month
  9. iQOO Pad Pro 8.8 Launch Teased; Confirmed to Feature 9,020mAh Battery
  10. Oppo Reno 17 Design Spotted in Leaked Hands-On Image; Oppo Reno 17 Pro Unlikely to Launch in India
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.